VORANIGO (R) was approved by Health Canada in August 2024 for the treatment of Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation in adults and pediatric patients aged ...

King's College London today announced the launch of VISI-ON-BRAIN (Cutting-edge Human In Vitro and In Silico Biomedical Tools on Brain Disorders), a ...

Pasithea Therapeutics Corp. ( KTTA) Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 4:00 PM EST ...

This is the “Exposed Cranium” nebula, also known as Nebula PMR 1. Located some 5,000 light-years away in the constellation Vela, it’s a massive, moribund star coming to the end of its fuel-burning ...

During the course of one conversation last Sunday, Gov. Gavin Newsom emerged as an unexpected new spokesman for people with dyslexia — while also stirring up a small-scale controversy over learning ...

Art: The Art Gallery of Sudbury presents IN 100 YEARS, an installation by landscape artist James Ridyard at 174 Elgin St.

After she played the last game of her career on the Nutter Center court Wednesday night, Lauren Scott took a seat just outside the dressing room and looked back over her four years at Wright State.

New research suggests that super-agers generate twice as many neurons as typical older adults. But you don't have to be a ...

The dominant theory in neuroscience has been that the sensory processing circuits in our brain are finalized in early ...

Neuron-powered computer chips can now be easily programmed to play a first-person shooter game, bringing biological computers a step closer to useful applications ...

Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, hemophilia and, recently, Huntington's disease, a fatal neurological ...

If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with relapsed or refractory BRAF-altered pediatric low-grade glioma, ...